| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Thomas Lowie, Stan Jourquin, Florian Debruyne, Laurens Chantillon, Geert Hoflack, Randy Boone, Geert Vertenten, Bart Sustronck, Bart Pardon, Jade Bokm. Associations of serostatus upon arrival with clinical respiratory disease, lung consolidation and growth in veal calves. Journal of dairy science. 2023-12-22. PMID:38135039. |
the main finding of this study was that calves who were seropositive for bovine respiratory syncytial virus (brsv) and bovine coronavirus (bcov) at arrival had reduced odds of developing lung consolidation at the peak of the outbreak, 0.58 or (95% ci: 0.38 - 0.89) and 0.37 or (95% ci: 0.20 - 0.69), respectively. |
2023-12-22 |
2023-12-25 |
cattle |
| Yufan Yang, Jianyang Wang, Jingbo Wang, Xiaotian Zhao, Tao Zhang, Yin Yang, Jiaohui Pang, Qiuxiang Ou, Linfang Wu, Xin Xu, Kunpeng Xu, Jingjing Zhao, Na Bai, Peng Yang, Sha Wang, Luhua Wang, Nan B. Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer. Cancer letters. 2023-12-15. PMID:38101608. |
at 1-month post-rt, ctdna mmvaf-high patients receiving consolidation immunotherapy exhibited improved progression-free survival (pfs) compared to those who did not (hr: 0.14, 95 % ci: 0.03-0.67). |
2023-12-15 |
2023-12-18 |
Not clear |
| Yufan Yang, Jianyang Wang, Jingbo Wang, Xiaotian Zhao, Tao Zhang, Yin Yang, Jiaohui Pang, Qiuxiang Ou, Linfang Wu, Xin Xu, Kunpeng Xu, Jingjing Zhao, Na Bai, Peng Yang, Sha Wang, Luhua Wang, Nan B. Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer. Cancer letters. 2023-12-15. PMID:38101608. |
from the baseline to week 4 of rt and/or 1-month post-rt, survival benefits from consolidation immunotherapy were exclusively observed in ctdna mmvaf-increased patients (pfs, hr: 0.39, 95 % ci: 0.14-1.15), especially in terms of distant metastasis (hr: 0.11, 95 % ci: 0.01-0.95). |
2023-12-15 |
2023-12-18 |
Not clear |
| Yang Li, Guodong Deng, Ning Liang, Pingping Hu, Yan Zhang, Lili Qiao, Yingying Zhang, Jian Xie, Hui Luo, Fei Wang, Fangjie Chen, Fengjun Liu, Deguo Xu, Jiandong Zhan. Chemoradiotherapy combined with immunotherapy in stage III non-small cell lung cancer: a systematic review and meta-analysis of efficacy and safety outcomes. Oncology. 2023-10-30. PMID:37903484. |
subgroup analysis showed that 24-month os rates were 60.7% (95%ci, 51.0%-70.3%) and 77.4% (95%ci, 73.2%-81.7%) at 1 year and 2 years of immune consolidation, respectively. |
2023-10-30 |
2023-11-08 |
Not clear |
| Yang Li, Guodong Deng, Ning Liang, Pingping Hu, Yan Zhang, Lili Qiao, Yingying Zhang, Jian Xie, Hui Luo, Fei Wang, Fangjie Chen, Fengjun Liu, Deguo Xu, Jiandong Zhan. Chemoradiotherapy combined with immunotherapy in stage III non-small cell lung cancer: a systematic review and meta-analysis of efficacy and safety outcomes. Oncology. 2023-10-30. PMID:37903484. |
the pooled 1-year completion rate for immune consolidation was 35.6% (95%ci, 31.3%-39.8%). |
2023-10-30 |
2023-11-08 |
Not clear |
| Franck Di Rienzo, Ursula Debarnot, Sébastien Daligault, Claude Delpuech, Julien Doyon, Aymeric Guillo. Brain plasticity underlying sleep-dependent motor consolidation after motor imagery. Cerebral cortex (New York, N.Y. : 1991). 2023-10-09. PMID:37814365. |
behavioral analyses revealed that overnight consolidation of motor learning through motor imagery outperformed wake-related consolidation (95% ci [0.02, 0.07], p < 0.001, rp2 = 0.05). |
2023-10-09 |
2023-10-15 |
human |
| Daria Gaut, Caspian Oliai, Jonathan Boiarsky, Shiliang Zhang, Amandeep Salhotra, Tali Azenkot, Vanessa E Kennedy, Vishesh Khanna, Karla Olmedo Gutierrez, Navika Shukla, Benjamin Moskoff, Gabriel Park, Michelle Afkhami, Anand Patel, Deepa Jeyakumar, Gabriel Mannis, Aaron C Logan, Brian A Jonas, Gary Schille. Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. Leukemia & lymphoma. 2023-10-06. PMID:37801340. |
multivariable logistic regression for patients with mrd threshold of detection of at least 0.1% showed that, when controlling for age, eln risk category, dose of cytarabine, and use of a combination agent, treatment with 1 cycle of consolidation cytarabine versus ≥2 cycles decreased the odds of conversion of aml to mrd-negative (or = 0.24, 95% ci 0.07-0.85, |
2023-10-06 |
2023-10-07 |
Not clear |
| Sebastian E Koschade, Jan A Stratmann, Pia S Zeiner, Fabian Finkelmeier, Jörg Chromik, Björn Steffen, Hubert Serve, Christian H Brandts, Olivier Ball. Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience. Annals of hematology. 2023-03-22. PMID:36947211. |
we retrospectively evaluated all ci from newly diagnosed non-promyelocytic aml patients receiving intensive induction or consolidation chemotherapy between 2007 and 2019 for imaging indications, diagnostic yield, and consequences. |
2023-03-22 |
2023-08-14 |
Not clear |
| Samar Tharwat, Gehad A Saleh, Marwa Saleh, Ahmad M Mounir, Dina G Abdelzaher, Ahmed M Salah, Mohammed Kamal Nassa. Chest CT Total Severity Score on Admission to Predict In-Hospital Mortality in COVID-19 Patients with Acute and Chronic Renal Impairment. Diagnostics (Basel, Switzerland). vol 12. issue 7. 2023-03-08. PMID:35885435. |
the univariate regression analysis showed an increasing odds of in-hospital mortality associated with higher respiratory rate (or 1.149, 95% ci 1.057−1.248, p = 0.001), total bilirubin (or 2.532, 95% ci 1.099−5.836, p = 0.029), lactate dehydrogenase (ldh) (or 1.001, 95% ci 1.000−1.003, p = 0.018), crp (or 1.010, 95% ci 1.002−1.017, p = 0.012), invasive mechanical ventilation (mv) (or 7.667, 95% ci 2.118−27.755, p = 0.002), a predominant pattern of pulmonary consolidation (or 21.714, 95% ci 4.799−98.261, p < 0.001), and high tss (or 2.082, 95% ci 1.579−2.745, p < 0.001). |
2023-03-08 |
2023-08-16 |
Not clear |
| Catherine Thieblemont, Bettina Altmann, Fabian Frontzek, Loïc Renaud, Loic Chartier, Nicolas Ketterer, Christian Récher, Viola Poeschel, Olivier Fitoussi, Gerhard Held, Olivier Casasnovas, Corinne Haioun, Franck Morschhauser, Bertram Glass, Nicolas Mounier, Herve Tilly, Andreas Rosenwald, German Ott, Georg Lenz, Thierry Jo Molina, Marita Ziepert, Norbert Schmit. Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/ DSHNHL analysis. Blood advances. 2023-01-30. PMID:36716220. |
younger high-risk patients with aaipi of 2-3 had 3-year ci rates of 1.6% and 4% after r-acvbp plus consolidation or r-(mega)cho(e)p, respectively (hazard ratio 2.4 (95% confidence interval: 0.8-7.4), p=0.118). |
2023-01-30 |
2023-08-14 |
Not clear |
| Brian T Hess, Anshu Giri, Yeonhee Park, Krina K Patel, Brian K Link, Grzegorz S Nowakowski, Seth M Maliske, Sonia Fortin, Julio C Chavez, Hayder Saeed, Brian T Hill, Alex V Mejia Garcia, Kami J Maddocks, Walter Hanel, Nina D Wagner-Johnston, Marcus R Messmer, Brad S Kahl, Marcus Watkins, Juan Pablo Alderuccio, Izidore S Lossos, Sunita Nathan, Victor M Orellana-Noia, Craig A Portell, Daniel J Landsburg, Emily C Ayers, Jorge J Castill. Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study. American journal of hematology. 2023-01-02. PMID:36588409. |
the 3-year pfs and os of patients treated with frontline chemotherapy alone was 65% (95% ci 50, 84) and 71% (95% ci 56, 89), respectively, compared to 85% (95% ci 72, 100) and 96% (95% ci 89, 100), respectively, in patients treated with combined frontline chemotherapy with radiation consolidation. |
2023-01-02 |
2023-08-14 |
human |
| Sara Magits, Ellen Boon, Linus De Meyere, Ann Dierckx, Ellen Vermaete, Tom Francart, Nicolas Verhaert, Jan Wouters, Astrid van Wieringe. Comparing the Outcomes of a Personalized Versus Nonpersonalized Home-Based Auditory Training Program for Cochlear Implant Users. Ear and hearing. 2022-12-19. PMID:36534665. |
there is a general agreement that more rigorous scientific study designs are needed to determine the effectiveness, generalization, and consolidation of at for ci users. |
2022-12-19 |
2023-08-14 |
Not clear |
| Mandeep Garg, Saurav Lamicchane, Muniraju Maralakunte, Uma Debi, Sahajal Dhooria, Inderpaul Sehgal, Nidhi Prabhakar, Manavjit Singh Sandh. Role of MRI in the Evaluation of Pulmonary Sequel Following COVID-19 Acute Respiratory Distress Syndrome (ARDS). Current problems in diagnostic radiology. 2022-10-17. PMID:36253228. |
t2w haste, t2w blade, and t1 vibe sequences showed 100% (95% ci, 40-100) sensitivity and 100% (95% ci, 3-100) specificity for detecting ggos, septal thickening/reticulations, pleural thickening, consolidation, and crazy-paving. |
2022-10-17 |
2023-08-14 |
human |
| Sun Yeop Lee, Sangwoo Ha, Min Gyeong Jeon, Hao Li, Hyunju Choi, Hwa Pyung Kim, Ye Ra Choi, Hoseok I, Yeon Joo Jeong, Yoon Ha Park, Hyemin Ahn, Sang Hyup Hong, Hyun Jung Koo, Choong Wook Lee, Min Jae Kim, Yeon Joo Kim, Kyung Won Kim, Jong Mun Cho. Localization-adjusted diagnostic performance and assistance effect of a computer-aided detection system for pneumothorax and consolidation. NPJ digital medicine. vol 5. issue 1. 2022-07-30. PMID:35908091. |
the cad achieved image-level auroc (95% ci) of 0.960 (0.945, 0.975), sensitivity of 0.933 (0.899, 0.959), specificity of 0.948 (0.930, 0.963), dice of 0.691 (0.664, 0.718), moderate calibration for consolidation, and image-level auroc of 0.978 (0.965, 0.991), sensitivity of 0.956 (0.923, 0.978), specificity of 0.996 (0.989, 0.999), dice of 0.798 (0.770, 0.826), moderate calibration for pneumothorax. |
2022-07-30 |
2023-08-14 |
Not clear |
| Joerg Hoffmann, Samira Roesner, Andreas Neubaue. Rituximab induces a flare-up of activated Neutrophil extracellular traps under in vitro Conditions. Immunopharmacology and immunotoxicology. 2022-06-13. PMID:35695816. |
contrary to the screening results asa showed no significant suppression of net formation in the consolidation experiments (mean of differences 0.43%; 95% ci -1.27 - 2.12%; p = 0.58).we conclude that rituximab therapy might further trigger activated net formation and should be applied with caution in patients with pro-inflammatory state and underlying autoimmune disease, thrombosis, or cancer. |
2022-06-13 |
2023-08-14 |
human |
| Qiang Cai, Natthaya Triphuridet, Yeqing Zhu, Nan You, Rowena Yip, David F Yankelevitz, Claudia I Henschk. Bronchiectasis in Low-Dose CT Screening for Lung Cancer. Radiology. 2022-04-19. PMID:35438565. |
bronchiectasis was more frequent with greater age (odds ratio [or] = 2.0 per decade; 95% ci: 1.7, 2.4); being a former smoker (or = 1.33; 95% ci: 1.01, 1.73); and having self-reported chronic obstructive pulmonary disease (or = 1.38; 95% ci: 1.02, 1.88), an elevated hemidiaphragm (or = 4; 95% ci: 2, 11), or consolidation (or = 5; 95% ci: 3, 11). |
2022-04-19 |
2023-08-13 |
human |
| Xuefei Sun, Yuchen Wu, Ruixian Xing, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Yuedan Chen, Qing Liu, Wenyuan Lai, Junhong Li, Yaming Wang, Shengjun Sun, Chunji Gao, Nan Ji, Yuanbo Li. Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China. Frontiers in oncology. vol 12. 2022-03-14. PMID:35280789. |
among 95 patients who completed sequential consolidation chemotherapy with either pemetrexed or etoposide plus cytarabine, the median pfs was 28 months (95% ci 17.11-38.89), and the estimated overall survival at 4 years was 78.7%. |
2022-03-14 |
2023-08-13 |
Not clear |
| Minghui Li, Fangfang Sun, Xiaoyue Bi, Yanjie Lin, Liu Yang, Yao Lu, Lu Zhang, Gang Wan, Wei Yi, Linqing Zhao, Yao Xi. Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients. Virologica Sinica. 2022-03-08. PMID:35257963. |
consolidation treatment of ≥ 12 weeks [odd ratio (or) 3.318, 95% confidence interval (ci) 1.077-10.224, p = 0.037) was a predictor of sustained functional cure, and hbeag-positivity at cessation of treatment (or 12.271, 95% ci 1.076-139.919, p = 0.043) was a predictor of hbsag reversion. |
2022-03-08 |
2023-08-13 |
Not clear |
| Lan Zhong, Kemin Li, Liang Song, Rutie Yi. The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2022-02-11. PMID:35148230. |
the pooled results revealed that overall survival (os) of patients treated with consolidation chemotherapy after concurrent chemoradiotherapy (ccrt + ct) was significantly superior to concurrent chemoradiotherapy (ccrt) alone (hr = 0.78, 95% ci: 0.69-0.88, |
2022-02-11 |
2023-08-13 |
Not clear |
| David R Spigel, Corinne Faivre-Finn, Jhanelle E Gray, David Vicente, David Planchard, Luis Paz-Ares, Johan F Vansteenkiste, Marina C Garassino, Rina Hui, Xavier Quantin, Andreas Rimner, Yi-Long Wu, Mustafa Özgüroğlu, Ki H Lee, Terufumi Kato, Maike de Wit, Takayasu Kurata, Martin Reck, Byoung C Cho, Suresh Senan, Jarushka Naidoo, Helen Mann, Michael Newton, Piruntha Thiyagarajah, Scott J Antoni. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022-02-02. PMID:35108059. |
consolidation durvalumab was associated with significant improvements in the primary end points of overall survival (os; stratified hazard ratio [hr], 0.68; 95% ci, 0.53 to 0.87; |
2022-02-02 |
2023-08-13 |
Not clear |